Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Cash from Operations (2024 - 2025)

Connect Biopharma Holdings (CNTB) has disclosed Cash from Operations for 2 consecutive years, with 11250000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 385.12% to 11250000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51206000.0 through Dec 2025, down 116.86% year-over-year, with the annual reading at 51206000.0 for FY2025, 116.86% down from the prior year.
  • Cash from Operations hit 11250000.0 in Q4 2025 for Connect Biopharma Holdings, up from 17406000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 591000.0 in Q1 2024 to a low of 17406000.0 in Q3 2025.